Description
Lipid-lowering agent.
The Ezetimibe / Simvastatin combination is indicated for the treatment of hyperlipidaemia, in those patients who cannot achieve or maintain adequate blood lipid levels, despite dietary modifications and monotherapy with a statin.
Ezetimibe / Simvastatin is recommended as an adjunct therapy to the diet to reduce elevated levels of total cholesterol, LDL cholesterol, apolipoprotein B, triglycerides, non-HDL cholesterol, and to increase HDL cholesterol in patients with heterozygous familial primary hypercholesterolaemia or hyperlipidaemia. mixed. Likewise, its use is indicated in those patients with homozygous familial hypercholesterolemia to reduce elevated total cholesterol and LDL cholesterol levels in combination with other lipid-lowering therapies (for example, apheresis).
Reviews
There are no reviews yet.